上海谊众药业股份有限公司 股东减持股份计划公告

Core Viewpoint - The shareholders of Shanghai Yizhong Pharmaceutical Co., Ltd. plan to reduce their holdings, which may impact the company's stock performance but is not expected to significantly affect its governance structure or ongoing operations [12]. Shareholder Holding Situation - As of the announcement date, shareholder Li Feng holds 7,001,280 shares, accounting for 3.39% of the total share capital; Li Xun holds 6,740,986 shares, or 3.26%; and Xu Yuexiang holds 1,544,335 shares, or 0.75%. These shareholders are considered acting in concert with the company's director and deputy general manager, Li Duan [2]. Details of the Reduction Plan - Li Feng intends to reduce his holdings by up to 511,350 shares through centralized bidding (0.247% of total share capital) and up to 2,067,000 shares through block trading (0.999%). Li Xun has the same reduction intentions as Li Feng [3]. - Xu Yuexiang plans to reduce her holdings by up to 1,044,335 shares through centralized bidding (0.505% of total share capital). The total reduction across the three shareholders is up to 6,201,035 shares, or 2.997% of the total share capital [4]. Reduction Timing and Conditions - The reduction through centralized bidding will occur within three months after 15 trading days from the announcement date, with a limit of 1% of total shares in any consecutive 90-day period. The block trading reduction will start three trading days after the announcement and is limited to 2% of total shares in any consecutive 90-day period [4]. Shareholder Commitments - The shareholders have made commitments regarding their holdings, including a lock-up period of twelve months post-listing, during which they will not transfer or manage their shares. This commitment extends to three full accounting years if the company has not achieved profitability [8][9].